U.S. Packaging Stock News

NYSE:NGVT
NYSE:NGVTChemicals

Ingevity (NGVT) Could Be 16% Below Fair Value After Germany Approval

Ingevity (NGVT) drew fresh attention after announcing that its Evotherm P35 warm mix asphalt additive received approval from Germany’s Federal Highway Research Institute, opening potential access to one of Europe’s stricter road materials markets. See our latest analysis for Ingevity. At a share price of $74.70, Ingevity has delivered a 24.31% year to date share price return and a 60.20% total shareholder return over the past year. This suggests that momentum has been building recently...
NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

Dollar Tree (DLTR) Stock Looks Like A Bargain On Cash Flow And Earnings

Dollar Tree stock has gained 23.3% over the past five years, yet the current share price of US$122.15 still screens as cheap on both an intrinsic value view and on market multiples. This puts the focus squarely on whether that apparent discount is justified. A 23.3% return over five years is steady rather than spectacular, which can leave room for valuation to matter more than momentum. Store closures paired with new openings and distribution upgrades may support earnings and cash flow, but...
NYSE:CARR
NYSE:CARRBuilding

Carrier Global (CARR) Faces Lowered Earnings Views, Is The Discount Enough?

Carrier Global (CARR) heads into its upcoming quarterly report with analysts expecting year over year declines in both earnings and revenue, and recent estimate cuts adding to uncertainty around the upcoming earnings call. See our latest analysis for Carrier Global. Carrier Global’s recent share price moves reflect this uncertainty, with the stock down 5.22% on a 1 month share price return, but still up 10.66% over 3 months and 27.24% year to date. The 1 year total shareholder return has...
NasdaqGS:FTNT
NasdaqGS:FTNTSoftware

Fortinet (FTNT) Stock Could Be 29% Overvalued On Fresh AI Security Push

Fortinet stock has delivered a strong 185.3% return over the past 5 years, yet current valuation checks suggest the shares are trading at a premium to an intrinsic value estimate based on a Discounted Cash Flow (DCF) model and to market multiples. Over 5 years, Fortinet has returned 185.3%, which puts added focus on whether the current share price leaves much room for error. New AI focused security and governance features for FortiEndpoint can support expectations for future cash flows...
NYSE:EMR
NYSE:EMRElectrical

Does New Refinery Optimization Software Shift the Industrial Software Narrative for Emerson Electric (EMR)?

In July 2026, Emerson introduced new Aspen Unified Scheduling software modules, Crude Schedule Optimization and Multi-Blend Optimization, to automate crude scheduling and product blending for refineries, integrating planning, scheduling and execution on a single platform. By reducing manual intervention and enabling rapid “what if” scenario testing, these tools could make Emerson’s refining customers more efficient and operationally resilient. We’ll now examine how automating crude...
NYSE:CNO
NYSE:CNOInsurance

CNO Financial Group (CNO) Stock May Be Reasonable As Equity Returns Support Value

CNO Financial Group stock has delivered a strong 158.7% return over the past five years, yet the valuation signals are pulling in different directions, with the Excess Returns intrinsic value estimate implying upside while earnings based multiples point to a richer price tag. CNO Financial Group's 158.7% five year return highlights how strongly long term shareholders have been rewarded, which naturally raises the bar for what counts as good value today. Expectations around the insurer's...
NYSE:GPN
NYSE:GPNDiversified Financial

How Morgan Stanley’s Upgrade and Platform Confidence At Global Payments (GPN) Has Changed Its Investment Story

Morgan Stanley recently upgraded Global Payments to Overweight, citing improved execution, strong feedback on its Genius and Worldpay platforms, and increased confidence in capital returns. This shift in analyst stance comes despite a multi-year period of weaker shareholder returns and mixed valuation signals, highlighting growing conviction in the company’s core payment technology franchise. We’ll now examine how Morgan Stanley’s greater confidence in Global Payments’ Genius and Worldpay...
NasdaqGS:FIVE
NasdaqGS:FIVESpecialty Retail

Five Below (FIVE) Could Be 23% Undervalued As It Opens Its 2,000th Store

Five Below (FIVE) is back in the spotlight after celebrating the opening of its 2,000th store in LaGrange, Georgia, an expansion milestone that gives investors fresh context for assessing the stock. See our latest analysis for Five Below. Alongside the 2,000th store opening and fresh product launches, Five Below’s recent momentum has been mixed, with a 7 day share price return of 6.13% and a 90 day share price return that declined 13.99%, while the 1 year total shareholder return of 47%...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

JD.com (JD) Draws Burry Support, Is The Stock Still Cheap?

Recent filings show that Michael Burry has increased his position in JD.com (JD), drawing fresh attention to the Chinese e-commerce company’s capital intensive logistics model and the long-term economics he views as attractive. See our latest analysis for JD.com. JD.com’s recent 11.6% 1 month share price return and 2.1% year to date share price return suggest improving momentum, even though the 1 year total shareholder return is still down 8.0% and the 5 year total shareholder return is down...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

AST SpaceMobile (ASTS) Stock Looks Overvalued After Its 15x Three Year Run

AST SpaceMobile has delivered a very large 3 year return, yet its current valuation checks and recent share price swings suggest a more cautious picture for anyone trying to judge what the stock is worth today. AST SpaceMobile has returned about 15x over the past 3 years, which puts extra pressure on today’s price to be backed by future execution rather than past gains. Progress on commercial roll out with partners like Bell Canada and recent regulatory approvals can support higher long term...
NYSE:CE
NYSE:CEChemicals

Celanese (CE) Could Be 30% Undervalued After Its Latest Dividend Declaration

Celanese (CE) recently declared a quarterly cash dividend of $0.03 per share, payable on August 10, 2026, to stockholders of record as of July 28, 2026, putting its income profile in focus. See our latest analysis for Celanese. Celanese shares now trade at US$48.36, with the 1 day share price return of 4.20% and 7 day gain of 2.44% set against a 90 day share price decline of 25.86% and a 1 year total shareholder return that is down 18.88%, pointing to fading longer term momentum despite the...
NYSE:DT
NYSE:DTSoftware

Dynatrace (DT) Could Be 47% Below Fair Value On August 5 Earnings Focus

Dynatrace (DT) is back in focus after the company scheduled the release of its first quarter fiscal 2027 results for August 5, 2026, ahead of the market open, along with a conference call and webcast. See our latest analysis for Dynatrace. Dynatrace’s share price has eased in the lead up to the earnings date, with a 1 day share price return of down 3.48% and a 7 day share price return of down 8.43%. However, the 90 day share price return of 20.62% contrasts with a 1 year total shareholder...
NasdaqGS:DOX
NasdaqGS:DOXIT

Amdocs (DOX) Could Be 38% Undervalued As Sales Weakness Clouds The Outlook

Recent analysis of Amdocs (DOX) has drawn attention to declining annual sales and earnings growth that trails peers, prompting investors to reassess expectations and sentiment around the stock’s near term prospects. See our latest analysis for Amdocs. At a share price of $51.22, Amdocs has seen its 90 day share price return fall 20.93%, and its 1 year total shareholder return decline 40.99%, signalling fading momentum as investors reassess growth and risk. If you are reassessing Amdocs and...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Arrowhead Pharmaceuticals (ARWR) Is Up 23.5% After Strong Plozasiran Phase 3 Data in Severe Hypertriglyceridemia

Arrowhead Pharmaceuticals recently reported topline results from its global Phase 3 SHASTA-3 and SHASTA-4 trials, showing that plozasiran achieved large triglyceride reductions and significantly lowered acute pancreatitis events in patients with severe hypertriglyceridemia while maintaining a favorable safety profile. Because plozasiran is already approved as REDEMPLO for familial chylomicronemia syndrome, these data give Arrowhead a basis to seek label expansion into the broader severe...
NYSE:RXO
NYSE:RXOTransportation

RXO (RXO) Could Be 33% Overvalued As Highway Partnership Draws Fresh Attention

RXO (RXO) stock is in focus after the company announced a partnership with Highway Inc., a carrier identity and fraud prevention provider, aimed at tightening network security and improving shipment visibility. See our latest analysis for RXO. RXO’s recent partnership news comes at a time when momentum in the stock is building, with a 30 day share price return of 11.15% and year to date share price return of 123.52%, alongside a 1 year total shareholder return of 68.53%. If this focus on...
NYSE:GPK
NYSE:GPKPackaging

Graphic Packaging Holding (GPK) Launches PaceSetter Ridgeline, Is The Stock Fairly Valued?

Graphic Packaging Holding (GPK) has drawn fresh attention after launching PaceSetter Ridgeline, its first uncoated recycled paperboard product. The launch opens a new market segment and broadens potential demand for its packaging solutions. See our latest analysis for Graphic Packaging Holding. Graphic Packaging Holding’s recent product launch comes as the stock shows short term momentum, with a 30 day share price return of 9.78% and a 90 day share price return of 17.82%, but a 1 year total...
NYSE:RYN
NYSE:RYNSpecialized REITs

What Rayonier (RYN)'s Wood Products Leadership Move and Dividend Declaration Means For Shareholders

Rayonier Inc. recently appointed Ryan Daniels as Senior Vice President, Wood Products, following his interim tenure, and its board declared a third-quarter cash dividend of US$0.26 per common share, payable on September 30, 2026, to shareholders of record on September 16, 2026. This combination of leadership continuity in the core Wood Products segment and ongoing cash returns via dividends highlights management’s focus on operational stability and shareholder income. We’ll now examine how...
NYSE:DHI
NYSE:DHIConsumer Durables

D.R. Horton (DHI) Stock May Be Cheap On Cash Flow While Broader Checks Stay Weak

D.R. Horton stock has delivered a 64.3% return over five years, yet current checks suggest the shares trade at a discount to an intrinsic value estimate based on Discounted Cash Flow (DCF) and also screen as undervalued on earnings multiples, even as broader valuation checks look less convincing. Over the past five years, D.R. Horton has returned 64.3%, which keeps long term holders in profit despite more recent share price weakness. Recent headlines around lower sales expectations and...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

Walmart (WMT) Stock Looks Overvalued On Cash Flow But Fair On Earnings

After a 146.1% total return over the past 5 years, Walmart stock now faces a valuation debate, with the Discounted Cash Flow (DCF) intrinsic value estimate indicating the shares trade at a premium while market multiples suggest the price is roughly in line with peers. Over 5 years, Walmart has returned 146.1%, which sets a high bar for any further upside to be supported by fundamentals. Partnerships that deepen Walmart’s role in areas like online returns and health and wellness can support...
NYSE:DD
NYSE:DDChemicals

DuPont De Nemours (DD) Launches Lithium Extraction Push On A Narrative That Sees Value Ahead

DuPont de Nemours (DD) has put its Direct Lithium Extraction portfolio in the spotlight, rolling out more than 20 technologies aimed at lithium brine projects as attention turns to this expanding market. See our latest analysis for DuPont de Nemours. Recent product launches in lithium extraction and water treatment appear to sit against a mixed share price backdrop for DuPont de Nemours, with a 7 day share price return of 3.54%, a 30 day share price decline of 3.41%, and a stronger backdrop...
NYSE:FMC
NYSE:FMCChemicals

Are Softer FMC (FMC) Earnings Expectations Quietly Rewriting Its Near-Term Investment Narrative?

FMC recently reported that analysts expect a year-over-year earnings decline on lower revenues for the June 2026 quarter, with consensus EPS estimates having been revised downward in the weeks before the announcement. This shift in expectations, reflected in a negative Earnings ESP and a Zacks Rank of 5, highlights how rapidly analyst sentiment can recalibrate around FMC’s near-term performance prospects. We’ll now examine how weaker analyst expectations and the negative Earnings ESP may...
NasdaqGS:SMCI
NasdaqGS:SMCITech

AI Stocks With Real Revenue Growth Investors May Want To Watch

Artificial intelligence stocks are sitting at the crossroads of powerful themes in today’s markets, from higher energy costs feeding through to inflation, to central banks keeping a close eye on data and geopolitics. While bond yields, oil prices, and policy signals shift across regions, companies directly exposed to the ChatGPT and AI build out, including semiconductors, cloud, and software, remain central to how businesses adapt. This AI Stocks screener focuses on those companies most...
NasdaqGS:CSWC
NasdaqGS:CSWCCapital Markets

Capital Southwest (CSWC) Stock Looks Expensive Relative To Fair Value

Capital Southwest stock has returned 66.9% over the past five years, and at a last close of US$23.69 the key tension for investors is that the Excess Returns intrinsic value model points to the shares trading at a premium while earnings-based multiples look roughly in line with the market, all against a low overall value score. Over five years, Capital Southwest has delivered a 66.9% total return, which puts current investors in the position of judging whether that run already reflects most...
NasdaqGS:ICFI
NasdaqGS:ICFIProfessional Services

How Investors Are Reacting To ICF International (ICFI) Slowing Growth And A Shrinking Backlog

In recent months, ICF International has reported softer quarterly results, with long-term revenue growth slowing to an annualized 3.6% and its backlog shrinking, pointing to weaker future orders. While earnings per share have grown 7.1% over five years, the company’s valuation already reflects much of this progress, prompting more cautious investor scrutiny of its fundamentals. We’ll now examine how the weaker backlog and slowing revenue growth could reshape ICF International’s previously...